SR

Surendra Ramsingh Mehta

Director Director DIN 01571279
DIN 01571279 First appointment Jul 2005 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2005
Shareholding value •••• Premium profile

About Surendra Ramsingh Mehta

Data last updated:

Surendra Ramsingh Mehta was a Director at Aguas Exim Limited (2014–2019) and Director at Meld Healthcare Products Private Limited (2005–2014). The companies operate in Healthcare and E-Commerce.

DIN 01571279
Primary Designation Director
Industry Healthcare
First Appointment 25 Jul 2005

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aguas Exim Limited U33100GJ1992PLC017237
Director11 Aug 20141992Active
Director25 Jul 20052005₹19.7 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aguas Exim Limited
Meld Healthcare Products Private Limited
Premium access

Shareholding and investment profile for Surendra Ramsingh Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Surendra Ramsingh Mehta

Surendra Ramsingh Mehta was first appointed on 25 Jul 2005 as Director at Meld Healthcare Products Private Limited. The most recent appointment on record is 11 Aug 2014 at Aguas Exim Limited.

Surendra Ramsingh Mehta held 2 earlier board appointments: Aguas Exim Limited (Director, 11 Aug 2014 to 08 Apr 2019); Meld Healthcare Products Private Limited (Director, 25 Jul 2005 to 11 Sep 2014).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available